This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Amyotrophic Lateral Sclerosis  • Neurogenetics  • Motor Neuron Disease  • Neuromuscular diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Jillian S. Parboosingh, MSc; Vincent Meininger, MD; Diane McKenna-Yasek; Robert H. Brown, Jr, MD; Guy A. Rouleau, MD

Arch Neurol. 1999;56:710-712.

Background  Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably lethal disease resulting from the premature death of motor neurons of the motor cortex, brainstem, and spinal cord. In approximately 15% of familial ALS cases, the copper/zinc superoxide dismutase gene is mutated; a juvenile form of familial ALS has been linked to chromosome 2. No cause has been identified in the remaining familial ALS cases or in sporadic cases and the selective neurodegenerative mechanism remains unknown. Deletions in 2 genes on chromosome 5q, SMN (survival motor neuron gene) and NAIP (neuronal apoptosis inhibitory protein gene), have been identified in spinal muscular atrophy, a disease also characterized by the loss of motor neurons. These genes are implicated in the regulation of apoptosis, a mechanism that may explain the cell loss found in the brains and spinal cords of patients with ALS.

Objective  To determine whether the mutations causing neurodegeneration in spinal muscular atrophy are present in patients with ALS in whom the copper/zinc superoxide dismutase gene is not mutated.

Patients and Methods  Patients in whom ALS was diagnosed were screened for mutations in the SMN and NAIP genes by single strand conformation analysis.

Results  We found 1 patient with an exon 7 deletion in the SMN gene; review of clinical status confirmed the molecular diagnosis of spinal muscular atrophy. No mutations were found in the remaining patients.

Conclusion  The SMN and NAIP gene mutations are specific for spinal muscular atrophy and do not predispose individuals to ALS.

From the Centre for Research in Neuroscience, McGill University and the Montreal General Hospital Research Institute, Montreal, Quebec (Ms Parboosingh and Dr Rouleau); Centre S. L. A., Hôtel Dieu de Paris, Paris, France (Dr Meininger); and Day Neuromuscular Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston (Ms McKenna-Yasek and Dr Brown).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(6):762-764.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
Gamez et al.
Neurology 2002;59:1456-1460.
ABSTRACT | FULL TEXT  

Clinical implications of the genetics of ALS and other motor neuron diseases
Orrell and Figlewicz
Neurology 2001;57:9-17.
ABSTRACT | FULL TEXT  

Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS
Veldink et al.
Neurology 2001;56:749-752.
ABSTRACT | FULL TEXT